Medtronic (NYSE:MDT) is cutting 81 jobs from its Diabetes unit ahead of its planned separation into MiniMed.
A Worker Adjustment and Retraining Notification (WARN) notice filed in California confirms the company’s plans to lay off 81 employees at its Northridge facility. MedTech Dive reported the news first.
The notice states that Medtronic notified the state of the planned workforce reduction on Feb. 5, 2026. It plans for the layoffs to go into effect on April 7, 2026.
The layoffs come as Medtronic looks to separate the Diabetes business into a publicly traded company called MiniMed.
Get the full story at our sister site, Drug Delivery Business News.
